Speak at the EuroMeeting 2014

 

26th Annual EuroMeeting 2014
March 25-27 | Vienna, Austria
Abstract submission deadline: May 29

Submit your presentation, session or tutorial abstracts for DIA’s Annual EuroMeeting and share your research with more than 3,000 professionals from around the world.

Session Abstract
A session abstract is a 90-minute session concept delivered lecture-style from the podium. The abstract author is considered the session chair and will coordinate efforts in recruiting speakers and manage the session. PowerPoint presentations are required. We welcome innovative ideas for session formats that will enhance interaction between stakeholders.

Presentation Abstract
A presentation abstract is for a 20-minute presentation in a specific topic area. The abstract author is considered the speaker and a PowerPoint presentation is required.

Tutorial Abstract
A tutorial is a ‘hands-on’, interactive learning experience. A tutorial consists of three hours of instruction with a 30-minute break halfway through. The abstract author is considered the instructor. One co-instructor may be recruited but cannot be from the same company/organization as the author.

To give your session, presentation or tutorial abstract the best chance of being accepted focus on the programme themes.

Hot-Topic/Stand-Alone Sessions
Each year, there are a number of sessions that do not fit directly under the programme themes. If your abstract clearly does not fit with any of the themes/topics outlined, you may submit it for consideration as a hot-topic/stand-alone presentation/session.

Find Out More | Submit Your Abstract

Sign up for DIA's Global SmartBrief: Break through the information clutter with FREE, twice-weekly email publication that gives quick, easy-to-read summaries of articles relevant to you. Get the latest news in drug development innovations worldwide wherever you are on your laptop or smart phone with SmartBrief’s wireless compatibility.

Health Economic Outcomes/Comparative Effectiveness Research/Health Technology Assessment Track at DIA's 49th Annual Meeting

TRACK 13: HEALTH ECONOMICS AND OUTCOMES (HEO)/COMPARATIVE EFFECTIVENESS RESEARCH (CER)/HEALTH TECHNOLOGY ASSESSMENT (HTA) Learning Objectives:  Describe current issues in measuring and communicating the medical need, health impact, and economic value associated with medical products How can clinical trial design impact reimbursement potential?

How are comparative effectiveness research and HTA applicable to the biopharmaceutical industry?

What are the pharma, safety, and patient perspectives on big data methodology?

2012 US Payer Landscape survey looks at CER and EBM use in coverage decision making.

What are benefits and outcomes of collaborations between payers and pharmaceutical companies?

How can we utilize EMRs as an  innovative methodology for evaluating Therapeutic Effectiveness?

What are different ways for incorporating patient-centered approaches in model development?

What are pros/cons of using observational methods to support comparative effectiveness research?

How can information sharing  be facilitated across Sponsors, Regulatory and HTA Agencies?

How do Public and Private Payers translate CER into Medical Payment Policy?

Join high-profile global regulators, industry professionals, and academia to discuss current regulatory landscape in Latin America

Plan your Attendance at LARC 2013 Take a look at this overview of the insightful sessions coming to the Latin American Regulatory Conference (LARC) 2013. Not registered yet? Book your seat before April 12 to save with an early-bird discount! Join high-profile global regulators, industry professionals, and academia to discuss the current regulatory landscape and its impact on future research and drug development at the event in Bogota, Colombia from May 15-16. Find Out More Download the Program Register 2012 VIDEO HIGHLIGHTS Watch videos from last year’s Latin American conferences and get a taste of what you can expect from these insightful events in 2013. IT ONLY TAKES A FEW MINUTES... Update your customer profile to ensure that you receive communications tailored to your specific area(s) of interest. Session Highlights Updates on Regional and Global Convergence with perspectives from Chile, Colombia, Canada, the PAHO and WHO Latin American Agencies Profiles by CIRS: Number of Reviewers, Inspectors, Timeliness, Predictability and Quality of a Full Review Case Study: Challenges faced by Regulators in the Adoption of Internationally Recognized Technical Guidance Documents and Standards Risk Based Approach to Inspections Integrity of the Supply Chain: Serialization, Counterfeits and Disposal of Expired Drugs Transparency of Review Process Health Technology Assessment Implementation of e-Submissions “Miracle” Drugs and Pharmaceutical Products Bordering Dietary Supplement Find Out More Download the Program Register

Email Preferences | My DIA | Forward to a Friend |

Highlights for upcoming Latin American Regulatory Conference - May 15-16, Bogota

Check out the Highlights for LARC 2013 Download the program and see what’s in store at the Latin American Regulatory Conference (LARC) 2013. Join global regulators, industry professionals and academia to discuss the current regulatory landscape and its impact on future research and drug development at the event in Bogota, Colombia from May 15-16. The LARC 2013 will focus on “Pharma-Co-Vergence” – the act of achieving pharmaceutical regulatory convergence through stakeholders’ collaboration – highlighting the true collaborative spirit of this multidisciplinary global conference. Attendees will learn how to define the various initiatives related to global regulatory environment and their impact on the access of medicines and future R&D in Latin America, and discuss the progress of the Pan American Network for Drug Regulatory Harmonization (PANDRH) convergence process and working groups. Download the Program Read More Register 2012 VIDEO HIGHLIGHTS Watch videos from last year’s Latin American conferences and get a taste of what you can expect from these insightful events in 2013. IT ONLY TAKES A FEW MINUTES... Update your customer profile to ensure that you receive communications tailored to your specific area(s) of interest. Featured Topics Regulatory Landscape and Convergence Initiatives Strengthening the Regulatory Framework Efforts Underway by Convergence Initiatives Reviews and Inspections Ethics Committee Research in the Regions Post-market Research Studies and Better Medicines to Influence Efficacy and Effectiveness Perspectives and Regulations of Pediatric Studies Drug Safety, Marketing Surveillance and Quality Control Monitoring Regulatory Concerns: Health Systems and Security of the Supply Chain Current Regulations of Biologics and Biosimilars Emerging Topics Who Should Attend Professionals involved in: Regulatory affairs Clinical research and development Clinical safety and pharmacovigilance Clinical trial and project management Drug development and discovery Medical and scientific affairs Preclinical development Quality assurance Research and development Strategic sourcing/planning Download the Program Read More Register

Email Preferences | My DIA | Forward to a Friend |

Professional development - Tutorials at EuroMeeting2013 4 March in Amsterdam

TUTORIAL (17)

• Title: Tutorial 01: Highlights on the Implementation of the New Pharmacovigilance Legislation with regards to Adverse Reaction Reporting Rules, Use of New International Standards and Signal Management in Eudravigilance
  Event Type: TUTORIAL

  Day: Monday, Mar, 04
  Time: 9:00AM - 12:30PM
• Title: Tutorial 02: Analysis of Safety Data from Clinical Trials
  Event Type: TUTORIAL
  Tracks: Theme 03 - Legal/Transparency-Risk Assessment

  Day: Monday, Mar, 04
  Time: 9:00AM - 12:30PM
• Title: Tutorial 03: Update on Practical Work with Variation Regulation
  Event Type: TUTORIAL
  Tracks: Theme 03 - Legal/Transparency-Risk Assessment

  Day: Monday, Mar, 04
  Time: 9:00AM - 12:30PM
• Title: Tutorial 04: Introduction to Medical Device Regulation
  Event Type: TUTORIAL
  Tracks: Theme 03 - Legal/Transparency-Risk Assessment

  Day: Monday, Mar, 04
  Time: 9:00AM - 12:30PM
• Title: Tutorial 05: Recent and Current developments in Pharmaceutical Law
  Event Type: TUTORIAL
  Tracks: Theme 03 - Legal/Transparency-Risk Assessment

  Day: Monday, Mar, 04
  Time: 9:00AM - 12:30PM
• Title: Tutorial 7: THE DIALOGUE AND NEGOTIATION PROCESS BETWEEN APPLYING COMPANY AND THE PAEDIATRIC COMMITTEE OF THE EUROPEAN MEDICINES AGENCY 
  Event Type: TUTORIAL
  Tracks: Theme 03 - Legal/Transparency-Risk Assessment

  Day: Monday, Mar, 04
  Time: 9:00AM - 12:30PM
• Title: Tutorial 08: Health Technology Assessment of Drugs and Medical Devices
  Event Type: TUTORIAL
  Tracks: Theme 03 - Legal/Transparency-Risk Assessment

  Day: Monday, Mar, 04
  Time: 9:00AM - 12:30PM
• Title: Tutorial 09: The European QP for Pharmacovigilance: Everything you ever Wanted to know but were afraid to ask
  Event Type: TUTORIAL
  Tracks: Theme 03 - Legal/Transparency-Risk Assessment

  Day: Monday, Mar, 04
  Time: 9:00AM - 12:30PM
• Title: Tutorial 10: Non-Clinical Safety Assessment in Global Pharmaceutical Development 
  Event Type: TUTORIAL
  Tracks: Theme 03 - Legal/Transparency-Risk Assessment

  Day: Monday, Mar, 04
  Time: 9:00AM - 12:30PM
• Title: Tutorial 11: Interactions between Regulatory and Intellectual Property, Privacy and Product Liability
  Event Type: TUTORIAL
  Tracks: Theme 03 - Legal/Transparency-Risk Assessment

  Day: Monday, Mar, 04
  Time: 9:00AM - 12:30PM
• Title: Tutorial 12: Development Safety Update Report (DSUR) Kick-off in 2011: Then and Know
  Event Type: TUTORIAL
  Tracks: Theme 03 - Legal/Transparency-Risk Assessment

  Day: Monday, Mar, 04
  Time: 9:00AM - 12:30PM
• Title: Tutorial 13: Technology Transfer for Biopharmaceuticals Workshop
  Event Type: TUTORIAL
  Tracks: Theme 03 - Legal/Transparency-Risk Assessment

  Day: Monday, Mar, 04
  Time: 9:00AM - 12:30PM
• Title: Tutorial 14: Pharmacovigilance Audits and Inspections
  Event Type: TUTORIAL
  Tracks: Theme 03 - Legal/Transparency-Risk Assessment

  Day: Monday, Mar, 04
  Time: 9:00AM - 12:30PM
• Title: Tutorial 15: Coding with Confidence
  Event Type: TUTORIAL
  Tracks: Theme 03 - Legal/Transparency-Risk Assessment

  Day: Monday, Mar, 04
  Time: 9:00AM - 12:30PM
• Title: Tutorial 16: Understanding Translational Medicine: Benefits and Innovative Approaches 
  Event Type: TUTORIAL
  Tracks: Theme 03 - Legal/Transparency-Risk Assessment

  Day: Monday, Mar, 04
  Time: 9:00AM - 12:30PM
• Title: Tutorial 17: Creating Compliant Clinical Study Reports for the EU and US
  Event Type: TUTORIAL
  Tracks: Theme 03 - Legal/Transparency-Risk Assessment

  Day: Monday, Mar, 04
  Time: 9:00AM - 12:30PM
• Title: Roundtable 01: GCP Inspections and Audit Findings
  Event Type: TUTORIAL

  Day: Monday, Mar, 04
  Time: 9:00AM - 12:30PM

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Sciences - Boston, June 23-27

About DIA 2013 DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Sciences is the largest multidisciplinary event that brings together a global network of professionals to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.

DIA 2013 49th Annual Meeting will:

• Provide a global unbiased platform to raise the level of discussion to facilitate innovation that will change the future of health care
• Provide comprehensive coverage of the full development and life cycle management process for all health care products
• Offer a holistic and integrated approach to the development and life cycle management of regulated health care products

To that end, DIA 2013 49th Annual Meeting provides the best opportunity to meet with people from around the world, share your views and knowledge, network, and build new relationships.

---

“A lot is being done to try to advance clinical development to become more efficient, to become more effective, and that the DIA provides an opportunity to share those kinds of ideas.” - Jeffrey McMullen, President and CEO, PharmaNet/i3

“Well, DIA really prides itself on providing a neutral forum. And that aspect of neutrality not only means that our attendees can have more confidence in the content, but it also means we have a lot more diversity of stakeholders presenting.” - Craig Lipset, DIA 2012 Program Chair

“It’s definitely one of the leading meetings that we attend.” - Josef von Rickenbach, Chairman and CEO, PAREXEL International

---

DIA’s Annual Meeting brings together all the stakeholders to enhance the health and well-being of patients.

HTA/Sustainability of Health Systems in Europe sessons at EuroMeeting2013 - 4-6 March in Amsterdam

Theme 01 - HTA/Sustainability of Health Systems in Europe (7)

• Title: THE EUROPEAN LANDSCAPE ON HTA - THE EUnetHTA JOINT ACTION
  Event Type: SESSIONDay: Tuesday, Mar, 05
  Time: 11:00AM - 12:30PM
• Title: COMPARATIVE EFFECTIVENESS AS PART OF THE PUBLIC ASSESSMENT REPORT (PAR)
  Event Type: SESSIONDay: Tuesday, Mar, 05
  Time: 2:00PM - 3:30PM
• Title: HTA AND PRICING POLICIES IN EU AFTER THE TRANSPARENCY DIRECTIVE
  Event Type: SESSIONDay: Tuesday, Mar, 05
  Time: 4:00PM - 5:30PM
• Title: FOCUS ON MANAGED ENTRY AGREEMENTS (AND REAL WORLD DATA)
  Event Type: SESSIONDay: Wednesday, Mar, 06
  Time: 9:00AM - 10:30AM
• Title: THE IMPACT OF THE NEW PHARMACOVIGILANCE LEGISLATION INSTRUMENTS ON HTAS
  Event Type: SESSIONDay: Wednesday, Mar, 06
  Time: 11:00AM - 12:30PM
• Title: THE PATIENTS’ PERSPECTIVE ON HTA
  Event Type: SESSIONDay: Wednesday, Mar, 06
  Time: 2:00PM - 3:30PM
• Title: HTA AND OFF-LABEL USE
  Event Type: SESSIONDay: Wednesday, Mar, 06
  Time: 4:00PM - 5:30PM

Session Highlights at EuroMeeting2013 - 4-6 March in Amsterdam

Session Highlights at the EuroMeeting 2013 Among the packed conference programme of the EuroMeeting are a few sessions, that you definitely don't want to miss. Hot topics, presentations delivered by high level speakers, and the opportunity to discuss current issues with fellow professionals and our special presenters. Opening Plenary: Public/Private Partnerships – Working Together in the Interest of Patients 4 March | 14:00-17:15Public-private partnerships (PPP) are collaborative relationships that transcend national boundaries. Each partnership brings together at least a corporation or an industry association and intergovernmental organisations to achieve a shared health-creating goal on the basis of a mutually agreed division of tasks. The positive aspects and concerns of these initiatives will be discussed. Moderator: Steffen Thirstrup, Head of Division, Medicines Assessment and Clinical Trials, Danish Health and Medicines Authority, Denmark Panelists: Jan Geissler, Director, EUPATI, Belgium Kemal Malik, Head of Global Development, Member of the Bayer HealthCare Executive Committee and Chief Medical Officer, Bayer HealthCare Pharmaceuticals, Germany Pat O’Mahony, Chief Executive, Irish Medicines Board, Ireland Luca Pani, Director General, Italian Medicines Agency (AIFA), Italy Andrzej Rys, Director of Health Systems and Products, European Commission, EU Harpreet Singh, Managing/CSO, Immamics Biotechnologies, Germany Sessions 1803/1804: GCP Hot Topics 5 March | 14:00-17:30 Session Chairs Gabriele Schwarz, Head, GCP Inspection Services, German Federal Institute for Drugs and Medical Devices (BfArM), Germany Beat Widler, Senior Partner, Widler & Schiemann, Switzerland The GCP Hot Topics Sessions that in recent editions of the EuroMeeting have been bringing together regulators, industry, CRO and academia professionals who want to get first hand information on newest trends, has by now become a EuroMeeting tradition. In 2013 the impact of changes and evolutions in technology on the conduct and quality management of clinical trials determine the programme of the GCP Hot Topic session. The focus will be on electronic health records (EHRs) when used as source documents or direct input source into clinical trial databases. As a second topic the session will deal with the challenges presented to sponsors and CROs when clinical trial activities are outsourced. This topic is not new but becomes increasingly a root cause of major and critical inspection findings. The program will be completed by the presentation of the White Paper on protocol violations that has been authored by the GCP SIAC. As in other years the roster of international speakers will involve senior representatives from health authorities, industry and CROs. The audience is invited to actively participate in the panel discussions by bringing examples or challenging statements. Delegates can anonymously submit topic-related questions or cases they would like to be discussed by the panel in advance to the session chairs via the DIA. Session 1805: EMA Roundtable – Scientific Committees United in Diversity 6 March | 9:00-10:30 Session Chair: Hans-Georg Eichler, Senior Medical Officer, European Medicines Agency, EU This roundtable will discuss how the EU Scientific Committees come together and interact at the European Medicines Agency to foster scientific excellence in the evaluation and supervision of medicines for the benefit of public health, while being enriched by the EU’s many different cultures and traditions. Session 1207: Regulatory Town Hall Meeting 6 March | 14:00-15:30 Session Co-Chairs: Guido Rasi, Executive Director, European Medicines Agency, EU and Christa Wirthumer-Hoche, Member CMDh, Deputy Head, Austrian Medicines and Medical Devices Agency (AGES), Austria. At the Town Hall Meeting attendees can put burning questions to experts about these topics: • Latest views on legislative changes • Implementation of the new pharmacovigilance legislation • Transparency • Drug shortages • Decision making • New approaches to licensing Download the full Conference Programme and read about these, and the 110+ other sessions, the exhibition and other activities the EuroMeeting has to offer. If you have any specific questions, please feel free to contact us. Make the most of your EuroMeeting Experience - register for a Pre-Conference Tutorial Monday, 4 March | 09:00-12:30 Read more... Download Advance Programme Register now Exhibiting Opportunities at the 25th Annual EuroMeeting Showcase your company’s products or services to key decision makers The exhibition hall is one of the busiest places at the meeting and provides a unique opportunity to interact with professionals from more than 50 countries working in pharma, devices, government, academia, healthcare delivery and other related occupations, together with representatives from patient organisations and much more. Apply for your Exhibition space today! More information... Download Application Form.... Exhibitor Prospectus Marketing & Hosting Information

Email Preferences | My DIA | Forward to a Friend |